Apollo Hospitals Enterprise Limited vs J B Chemicals & Pharmaceuticals Ltd

A side-by-side comparison of Apollo Hospitals Enterprise Limited (APOLLOHOSP) and J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

Apollo Hospitals Enterprise Limited vs J B Chemicals & Pharmaceuticals Ltd are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.

  • Valuation13
  • Profitability13
  • Growth20
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

JBCHEPHARM takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

58.43
P/E ratio
53.34
13.46
P/B ratio
9.30
0.22%
Dividend yield
0.91%
₹135.04
EPS
₹45.16

Profitability

JBCHEPHARM takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

20.48%
Return on equity
17.06%
17.31%
Return on capital
23.01%
14.94%
EBITDA margin
26.70%
7.94%
Net margin
17.10%

Growth

APOLLOHOSP takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
9.62%
33.35%
Profit CAGR (3Y)
20.06%

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.14L Cr
Market cap
₹37,736 Cr
₹25,229 Cr
Revenue
₹4,148 Cr
₹2,003 Cr
Net profit
₹709 Cr
0.90
Debt / equity
0.00
Apollo Hospitals Enterprise Limited
  • + ["Company has delivered good profit growth of 71.0% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
  • − ["Stock is trading at 11.97 times its book value"]
J B Chemicals & Pharmaceuticals Ltd
  • + ["Company has reduced debt.", "Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 40.3%", "Promoter holding has increased by 1.25% over last quarter."]
  • − ["Stock is trading at 9.30 times its book value", "Promoter holding has decreased over last 3 years: -5.11%", "Working capital days have increased from 86.6 days to 126 days"]
Apollo Hospitals Enterprise Limited full analysis J B Chemicals & Pharmaceuticals Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.